During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Hepatitis C virus (HCV) infected patients are known to be at risk of developing liver
complications ie cirrhosis and liver cancer. However, the risks of morbidity and mortality are …

Chronic hepatitis C virus (HCV) infection occurs in about 3 percent of the world's population
and is a major cause of liver disease. HCV infection is also associated with …

After the development of diagnostic tests for hepatitis A and hepatitis B viruses in the 1970s,
an additional parenterally transmitted agent responsible for the majority of …

BACKGROUND: Mixed cryoglobulinemia (MC) is a systemic vasculitis secondary to
circulating immune complex deposition in the small vessels. In the overwhelming majority of …

The clinical course of chronic hepatitis C virus (HCV) infection is characterized by possible
development of both liver and extrahepatic disorders. The tropism of HCV for the lymphoid …

Serum cryoglobulins are found in a wide spectrum of disorders but are often transient and
without clinical implications. Monoclonal cryoglobulins are usually associated with …

Hepatitis C virus (HCV) has been shown to affect many tissues other than liver. However, of
the many extrahepatic manifestations (EMs) that have been associated with HCV, including …

Mixed cryoglobulinemia (MC), type II and type III, refers to the presence of circulating
cryoprecipitable immune complexes in the serum and manifests clinically by a classical triad …

Hepatitis C virus (HCV), which is both a hepatotropic and a lymphotropic virus, has been
proposed as a possible causative agent of mixed cryoglobulinaemia. This 'benign' …